Overview Fundamentals API Earnings EOD API Sample Code Pricing

Comera Life Sciences Holdings Inc (CMRA PINK) stock market data APIs

$0.026 0(0%) as of July 12, 2024
Price chart is built with Anychart

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

Comera Life Sciences Holdings Inc Financial Data Overview

922 K
30 738 K
1 000 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CMRA',
Type: 'Common Stock',
Name: 'Comera Life Sciences Holdings Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG017NL7GF2',
CIK: '1907685',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2022-05-19',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Comera Life Sciences Holdings Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 000 K
  • EBITDA -7 546 982
  • Earnings Per Share -0.22
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Comera Life Sciences Holdings Inc Earnings via APIs

  • Latest Release 2023-09-30
  • EPS/Forecast NaN

Get Comera Life Sciences Holdings Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?